Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
Giulia Fregni(Délégation Paris 5), Anne Caignard(Inserm), Emmanuelle Fourmentraux-Neves(Inserm), J. Chanal(Délégation Paris 5), E. Maubec(Délégation Paris 7), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Isabelle Scheer-Senyarich(Délégation Paris 7), Marie‐Françoise Avril(Délégation Paris 7), Sarra Mazouz-Dorval(Inserm), Eduardo Marinho(Université Paris Cité), Isabelle Cremer(Inserm)
Cited by 65
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2014|806
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
|Nature Medicine|2022|637
Classification of current anticancer immunotherapies
|Oncotarget|2014|469